Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders : Proceedings of a Workshop
Book Details
Format
Paperback / Softback
ISBN-10
0309691370
ISBN-13
9780309691376
Publisher
National Academies Press
Imprint
National Academies Press
Country of Manufacture
GB
Country of Publication
GB
Publication Date
Dec 28th, 2022
Print length
96 Pages
Product Classification:
Neurology & clinical neurophysiology
Ksh 2,900.00
Publisher Out of Stock
Delivery Location
Delivery fee: Select location
Secure
Quality
Fast
Psychiatric illnesses - such as major depressive disorder, anxiety disorder, substance use disorder, and posttraumatic stress disorder (PTSD) - are widely prevalent and represent a substantial health burden worldwide. Yet, conventional medications for mental illnesses often fail to provide relief to patients' disruptive and disabling symptoms. Existing and emerging evidence that psychedelics (e.g., LSD and psilocybin) and entactogens (e.g., MDMA) may be useful as tools to alleviate mental illness has sparked a renaissance of interest by investigators, clinicians, drug developers, and patient advocates in recent years. While promising data on therapeutic efficacy has energized research and development, resolving the mechanisms of action will be important for optimizing the efficacy and safety of these medicines. Further, evaluating the effect of psychedelics and entactogens on mood and behavior comes with unique challenges still in need of resolution. These include unresolved questions relating to blinding, placebo and nocebo effects, and the impact of psychosocial contexts. In response to this renewed interest, the National Academies of Sciences, Engineering, and Medicine's Forum on Neuroscience and Nervous System Disorders convened a workshop on March 29-30, 2022. The workshop brought together a diverse group of stakeholders to explore the use of psychedelics and entactogens as treatments for psychiatric disorders. This Proceedings of a Workshop summarizes the presentations and discussions of the workshop. Table of ContentsFront Matter1 Introduction and Background2 History and Current Status of Psychedelics and Entactogens for the Treatment of Psychiatric Disorders3 Mechanisms of Action and Key Research Gaps for Psychedelics and Entactogens4 Advancing Clinical Development: Challenges and Opportunities5 Anticipating Implementation to Guide Clinical Research and Development6 Reflecting on the Road AheadAppendix A: ReferencesAppendix B: Workshop Agenda
Get Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders by at the best price and quality guaranteed only at Werezi Africa's largest book ecommerce store. The book was published by National Academies Press and it has pages.